HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells (Q39731790)

14 September 2017

title

HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells (English)

1 reference

14 September 2017

0 references

cervix uterine cancer

1 reference

Junye Liu

1

1 reference

14 September 2017

Jing Zhang

2

1 reference

14 September 2017

Xiaowu Wang

3

1 reference

14 September 2017

Yan Li

4

1 reference

14 September 2017

Yongbin Chen

5

1 reference

14 September 2017

Kangchu Li

6

1 reference

14 September 2017

Jian Zhang

7

1 reference

14 September 2017

Libo Yao

8

1 reference

14 September 2017

Guozhen Guo

9

1 reference

14 September 2017

language of work or name

English

0 references

publication date

3 March 2010

1 reference

Experimental Cell Research

14 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 September 2017

volume

316

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

1985-1993

1 reference

Hypoxia in cancer: significance and impact on clinical outcome

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

HIF-1: a key mediator in hypoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

HIF-1 and tumour radiosensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

NDRG2: a Myc-repressed gene involved in cancer and cell stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Aberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Expression of NDRG2 in clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

NDRG2 expression and mutation in human liver and pancreatic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Preparation and application of monoclonal antibody against hNDRG2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Resazurin assay of radiation response in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

The physical and functional interaction of NDRG2 with MSP58 in cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.028

10.1016/J.YEXCR.2010.02.028

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference